Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of
Journal
Gastroenterology research and practice
ISSN: 1687-6121
Titre abrégé: Gastroenterol Res Pract
Pays: Egypt
ID NLM: 101475557
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
07
2019
revised:
10
11
2019
accepted:
25
11
2019
entrez:
15
1
2020
pubmed:
15
1
2020
medline:
15
1
2020
Statut:
epublish
Résumé
To evaluate the eradication rate, safety, and compliance of minocycline-containing bismuth quadruple regimens in patients with an untreated A total of 360 patients with an untreated No significant differences were observed at baseline data among the three groups (
Identifiants
pubmed: 31933634
doi: 10.1155/2019/9251879
pmc: PMC6942845
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9251879Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2019 Lingyun Zhang et al.
Déclaration de conflit d'intérêts
All authors declare no conflicts of interest.
Références
J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:108-11
pubmed: 22486882
J Gastrointestin Liver Dis. 2014 Dec;23(4):367-70
pubmed: 25531993
Gastroenterology. 2016 Jul;151(1):51-69.e14
pubmed: 27102658
Rinsho Ketsueki. 2003 Jul;44(7):480-2
pubmed: 12931570
Gan To Kagaku Ryoho. 2010 Oct;37(10):1961-4
pubmed: 20948264
Gut. 2013 Jan;62(1):34-42
pubmed: 22580412
Zhonghua Nei Ke Za Zhi. 2015 Dec;54(12):1013-7
pubmed: 26887366
World J Gastroenterol. 2015 Mar 7;21(9):2786-92
pubmed: 25759550
Clin Ther. 2005 Sep;27(9):1329-42
pubmed: 16291409
Am J Gastroenterol. 2014 Apr;109(4):535-41
pubmed: 24642580
J Dig Dis. 2015 Aug;16(8):464-70
pubmed: 26147515
Zhonghua Nei Ke Za Zhi. 2017 Jul 1;56(7):532-545
pubmed: 28693066
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
Helicobacter. 2009 Oct;14(5):86-90
pubmed: 19751432
Control Clin Trials. 2000 Dec;21(6):540-51
pubmed: 11146148
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):262-7
pubmed: 16460484